2018
Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012–2013 Medical Expenditure Panel Survey
Singh J, Valero‐Elizondo J, Salami JA, Warraich HJ, Ogunmoroti O, Spatz ES, Desai N, Rana JS, Virani SS, Blankstein R, Blaha MJ, Nasir K. Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012–2013 Medical Expenditure Panel Survey. Journal Of The American Heart Association 2018, 7: e007874. PMID: 29686026, PMCID: PMC6015292, DOI: 10.1161/jaha.117.007874.Peer-Reviewed Original ResearchConceptsAtherosclerotic cardiovascular diseaseAbsence of ASCVDCancer patientsMedical Expenditure PanelCRF profileRepresentative US adult populationHealthcare expendituresCardiovascular risk profileRisk factor profileBurden of cancerMean annual costAnnual healthcare expendituresMedical Expenditure Panel SurveyUS adult populationLower medical expendituresYears of ageLower healthcare costsCardiovascular managementCardiovascular diseaseHigh prevalenceRepresentative adult sampleUS adultsTwo-part econometric modelHealthcare costsEconomic burden
2017
Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012–2013 Medical Expenditures Panel Survey
Salami JA, Valero‐Elizondo J, Ogunmoroti O, Spatz ES, Rana JS, Virani SS, Blankstein R, Younus A, Arrieta A, Blaha MJ, Veledar E, Nasir K. Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012–2013 Medical Expenditures Panel Survey. Journal Of The American Heart Association 2017, 6: e004996. PMID: 28600400, PMCID: PMC5669151, DOI: 10.1161/jaha.116.004996.Peer-Reviewed Original ResearchConceptsModifiable risk factorsAtherosclerotic cardiovascular diseaseCardiovascular diseaseRisk factorsPharmaceutical expenditureMedication-related expendituresSignificant marginal increaseSurvey's complex designInadequate physical activityMedical Expenditure Panel SurveyMedical Expenditure PanelHigher healthcare spendingASCVD patientsDiabetes mellitusMost deathsPhysical activityTotal pharmaceutical expenditureAdjusted relationshipMedicationsDiseaseHealthcare spendingMellitusPatientsAssociationAdults
2016
Economic Impact of Moderate‐Vigorous Physical Activity Among Those With and Without Established Cardiovascular Disease: 2012 Medical Expenditure Panel Survey
Valero‐Elizondo J, Salami JA, Osondu CU, Ogunmoroti O, Arrieta A, Spatz ES, Younus A, Rana JS, Virani SS, Blankstein R, Blaha MJ, Veledar E, Nasir K. Economic Impact of Moderate‐Vigorous Physical Activity Among Those With and Without Established Cardiovascular Disease: 2012 Medical Expenditure Panel Survey. Journal Of The American Heart Association 2016, 5: e003614. PMID: 27604455, PMCID: PMC5079024, DOI: 10.1161/jaha.116.003614.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedArrhythmias, CardiacCardiovascular DiseasesCase-Control StudiesCoronary Artery DiseaseDiabetes MellitusExerciseFemaleHealth ExpendituresHealth ServicesHeart FailureHumansHypercholesterolemiaHypertensionMaleMiddle AgedObesityPeripheral Arterial DiseaseRetrospective StudiesSmokingStrokeUnited StatesYoung AdultConceptsModerate-vigorous physical activityDays/weekPhysical activityHealth care expendituresTotal annual health care expendituresLower health care expendituresAnnual health care expendituresCare expendituresLower health care spendingModifiable risk factorsCardiovascular disease outcomesMedical Expenditure Panel SurveyFinal study sampleYears of ageQuality of lifeMedical Expenditure PanelLink logCVD statusHealth care spendingRisk factorsDisease outcomeStudy populationUS adultsRepresentative cohortTwo-part econometric model